Info
Dr. Karen Reckamp from City of Hope Cancer Center in Duarte, CA describes which patients with advanced NSCLC she seeks molecular marker testing on, and the particular markers she prioritizes.
9 anni fa
#adenocarcinoma, #advanced, #cancer, #cancergrace, #center, #city, #egfr, #grace, #histology, #hope, #karen, #kras, #molecular, #mutation, #nsclc, #of, #oncology, #squamous, #targeted, #therapy
Scopri di più
Cerca
